Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.

Phinney DG, Pittenger MF.

Stem Cells. 2017 Apr;35(4):851-858. doi: 10.1002/stem.2575. Epub 2017 Mar 10. Review. Erratum in: Stem Cells. 2017 Sep;35(9):2103.

2.

Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects.

Fontaine MJ, Shih H, Schäfer R, Pittenger MF.

Transfus Med Rev. 2016 Jan;30(1):37-43. doi: 10.1016/j.tmrv.2015.11.004. Epub 2015 Dec 1. Review.

PMID:
26689863
3.

MSCs: Scientific Support for Multiple Therapies.

Pittenger MF, Le Blanc K, Phinney DG, Chan JK.

Stem Cells Int. 2015;2015:280572. doi: 10.1155/2015/280572. Epub 2015 Jul 29. No abstract available.

4.

Pim-1 kinase cooperates with serum signals supporting mesenchymal stem cell propagation.

Zhao Y, Hu J, Buckingham B, Pittenger MF, Wu ZJ, Griffith BP.

Cells Tissues Organs. 2014;199(2-3):140-9. doi: 10.1159/000367684. Epub 2014 Nov 11.

5.

MSCs: science and trials.

Pittenger MF.

Nat Med. 2013 Jul;19(7):811. doi: 10.1038/nm.3219. No abstract available.

PMID:
23836215
6.

Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction.

Zhao Y, Li T, Wei X, Bianchi G, Hu J, Sanchez PG, Xu K, Zhang P, Pittenger MF, Wu ZJ, Griffith BP.

Stem Cells Transl Med. 2012 Sep;1(9):685-95. doi: 10.5966/sctm.2012-0027. Epub 2012 Sep 7. Erratum in: Stem Cells Transl Med. 2013 Aug;2(8):633.

7.

Stem Cells' position statement on hESC research.

Stojkovic M, Pittenger MF, Nolta JA, Lako M, Lappin TR, Murphy MJ Jr.

Stem Cells. 2010 Sep;28(9):1A. doi: 10.1002/stem.517. No abstract available.

8.

Mesenchymal stem cells from adult bone marrow.

Pittenger MF.

Methods Mol Biol. 2008;449:27-44. doi: 10.1007/978-1-60327-169-1_2.

PMID:
18370081
9.

Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.

Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, Pittenger MF, van Zijl PC, Huang J, Bulte JW.

Stroke. 2008 May;39(5):1569-74. doi: 10.1161/STROKEAHA.107.502047. Epub 2008 Mar 6.

10.

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction.

Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BM, Wahl RL, Bulte JW.

Circulation. 2005 Sep 6;112(10):1451-61. Epub 2005 Aug 29.

11.

Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model.

Bulte JW, Kostura L, Mackay A, Karmarkar PV, Izbudak I, Atalar E, Fritzges D, Rodriguez ER, Young RG, Marcelino M, Pittenger MF, Kraitchman DL.

Acad Radiol. 2005 May;12 Suppl 1:S2-6. No abstract available.

PMID:
16106536
12.

Mesenchymal stem cells: progress toward promise.

Le Blanc K, Pittenger M.

Cytotherapy. 2005;7(1):36-45. Review.

PMID:
16040382
13.

Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis.

Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW.

NMR Biomed. 2004 Nov;17(7):513-7.

PMID:
15526348
14.

Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.

Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF.

Blood. 2004 Nov 15;104(10):3410-2; author reply 3412-3. No abstract available. Erratum in: Blood. 2005 Jan 15;105(2):473.

PMID:
15525839
15.

Human mesenchymal stem cells modulate allogeneic immune cell responses.

Aggarwal S, Pittenger MF.

Blood. 2005 Feb 15;105(4):1815-22. Epub 2004 Oct 19.

PMID:
15494428
16.

Mesenchymal stem cells and their potential as cardiac therapeutics.

Pittenger MF, Martin BJ.

Circ Res. 2004 Jul 9;95(1):9-20. Review.

PMID:
15242981
17.

111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction.

Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL.

Nucl Med Commun. 2003 Nov;24(11):1149-54.

PMID:
14569169
18.

In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW.

Circulation. 2003 May 13;107(18):2290-3. Epub 2003 May 5.

PMID:
12732608
19.

Cell therapy in the heart: cell production, transplantation, and applications.

Cahill KS, Toma C, Pittenger MF, Kessler PD, Byrne BJ.

Methods Mol Biol. 2003;219:73-81. No abstract available.

PMID:
12596999
20.

Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects.

Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ.

Ann Thorac Surg. 2002 Jun;73(6):1919-25; discussion 1926.

PMID:
12078791
21.

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.

Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD.

Circulation. 2002 Jan 1;105(1):93-8.

PMID:
11772882
22.

Human mesenchymal stem cells maintain transgene expression during expansion and differentiation.

Lee K, Majumdar MK, Buyaner D, Hendricks JK, Pittenger MF, Mosca JD.

Mol Ther. 2001 Jun;3(6):857-66.

23.

Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma.

Pittenger MF, Mosca JD, McIntosh KR.

Curr Top Microbiol Immunol. 2000;251:3-11. No abstract available.

PMID:
11036752
24.

Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation.

Mbalaviele G, Abu-Amer Y, Meng A, Jaiswal R, Beck S, Pittenger MF, Thiede MA, Marshak DR.

J Biol Chem. 2000 May 12;275(19):14388-93.

25.

Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase.

Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF.

J Biol Chem. 2000 Mar 31;275(13):9645-52.

26.

Multilineage potential of adult human mesenchymal stem cells.

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR.

Science. 1999 Apr 2;284(5411):143-7.

27.

Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow.

Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF.

Tissue Eng. 1998 Winter;4(4):415-28.

PMID:
9916173
28.
29.

Functional properties of non-muscle tropomyosin isoforms.

Pittenger MF, Kazzaz JA, Helfman DM.

Curr Opin Cell Biol. 1994 Feb;6(1):96-104. Review.

PMID:
8167032
31.

Reconstruction of tubulin gene regulation in cultured mammalian cells.

Lau JT, Pittenger MF, Havercroft JC, Cleveland DW.

Ann N Y Acad Sci. 1986;466:75-88. No abstract available.

PMID:
3460447
34.

Elevation of tubulin levels by microinjection suppresses new tubulin synthesis.

Cleveland DW, Pittenger MF, Feramisco JR.

Nature. 1983 Oct 20-26;305(5936):738-40.

PMID:
6633643
35.
36.

Autoregulatory control of expression of alpha and beta tubulin.

Cleveland DW, Pittenger MF, Lopata MA.

J Submicrosc Cytol. 1983 Jan;15(1):353-8. No abstract available.

PMID:
6188853

Supplemental Content

Loading ...
Support Center